People diagnosed with rarer forms of cancer are 50% more likely to die within 5 years than those diagnosed with more common cancers. RareCan was founded to address this inequality.
RareCan is the only health tech company in the UK that specialises in supporting patients with rare cancers. We connect people with rare cancer to the resources and tools they need to understand and manage their lives with cancers. Through doing this we are creating a research platform to accelerate the pace that new diagnostics and treatments are brought to market for rare cancer patients.
By bringing together rare cancer patients and researchers, and improving access to rare cancer tumour tissue samples, longitudinal clinical data and genetic data, first in the UK and then globally, RareCan is working towards a world where rare cancers are treatable diseases. Together we can.
